Skip to main content
OpenTrials

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,144 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment

NCT00980330

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • La Jolla, California, United States
  • Los Angeles, California, United States
  • Jacksonville, Florida, United States
  • Miami, Florida, United States
View all 78 locations
View Trial Details
Completed

Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR

NCT00532701

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • National Taiwan University Hospital, Yun-Lin Branch Douliu, Taiwan
  • Kaohsiung Medical University Kaohsiung City, Taiwan
  • Kaohsiung Municipal Hsiao-Kang Hospital Kaohsiung City, Taiwan
  • Paochien Hospital Pingtung City, Taiwan
View Trial Details
Completed

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

NCT01241760

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
Locations
  • La Jolla, California, United States
  • Los Angeles, California, United States
  • San Diego, California, United States
  • Aurora, Colorado, United States
View all 99 locations
View Trial Details
Completed

Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)

NCT01604850

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • SCTI Research Foundation Coronado, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • Peter J. Ruane, MD, Inc. Los Angeles, California, United States
  • Anthony Mills MD, Inc. Los Angeles, California, United States
View all 67 locations
View Trial Details
Completed

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

NCT01329978

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Alabama Liver and Digestive Specialist Montgomery, Alabama, United States
  • Clopton Clinic Jonesboro, Arkansas, United States
  • Advanced Clinical Research Institute Anaheim, California, United States
  • Providence Clinical Research Burbank, California, United States
View all 46 locations
View Trial Details
Completed

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

NCT01542788

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • SCTI Research Foundation Liver Center Coronado, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • Lightspeed Medical Los Angeles, California, United States
View all 63 locations
View Trial Details
Completed

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

NCT00595465

Conditions
Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie Vienna, Austria
  • Berliner Zentrum Reise- und Tropenmedizin Berlin, Germany
  • Klinikum der Universität München, Abteilung für Infektions- und Tropenmedizin Munich, Germany
  • Klinik und Poliklinik für Innere Medizin der Universität Rostock Rostock, Germany
View Trial Details
Completed

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

NCT00595309

Conditions
Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie Vienna, Austria
  • Zentrum für Reisemedizin, Dependance für klinische Studien Vienna, Austria
  • Berliner Zentrum Reise- und Tropenmedizin Berlin, Germany
View Trial Details

Related conditions